Cargando…
An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° det...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709821/ https://www.ncbi.nlm.nih.gov/pubmed/34331215 http://dx.doi.org/10.1007/s12350-021-02715-6 |
_version_ | 1784623027914276864 |
---|---|
author | Schatka, Imke Bingel, Anne Schau, Franziska Bluemel, Stephanie Messroghli, Daniel R. Frumkin, David Knebel, Fabian Diekmann, Sonja M. Elsanhoury, Ahmed Tschöpe, Carsten Hahn, Katrin Amthauer, Holger Rogasch, Julian M. M. Wetz, Christoph |
author_facet | Schatka, Imke Bingel, Anne Schau, Franziska Bluemel, Stephanie Messroghli, Daniel R. Frumkin, David Knebel, Fabian Diekmann, Sonja M. Elsanhoury, Ahmed Tschöpe, Carsten Hahn, Katrin Amthauer, Holger Rogasch, Julian M. M. Wetz, Christoph |
author_sort | Schatka, Imke |
collection | PubMed |
description | BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° detector angle) or L-mode (90°). METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive and 38 negative patients (reference: endomyocardial biopsy or clinical diagnosis), Perugini scores and heart-to-contralateral (H/CL) count ratios were derived from planar images 1 hour and 3 hour p.i. RESULTS: In phantom measurements, accuracy of myocardial CRpeak at SBR 10:1 (H-mode, 0.95-0.99) and reproducibility at 5:1 (H-mode, 1.02-1.14) was comparable for H-mode and L-mode. However, L-mode showed higher variability of background counts and sphere CRpeak throughout the field of view than H-mode. In patients, sensitivity/specificity were ≥ 95% for H/CL ratios at both time points and visual scoring 3 hour. At 1 hour, visual scores showed specificity of 89% and reduced reader’s confidence. CONCLUSIONS: Early DPD images provided no additional value for visual scoring or H/CL ratios. In SPECT/CT, H-mode is preferred over L-mode, especially if quantification is applied apart from the myocardium. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02715-6. |
format | Online Article Text |
id | pubmed-8709821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-87098212022-01-10 An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis Schatka, Imke Bingel, Anne Schau, Franziska Bluemel, Stephanie Messroghli, Daniel R. Frumkin, David Knebel, Fabian Diekmann, Sonja M. Elsanhoury, Ahmed Tschöpe, Carsten Hahn, Katrin Amthauer, Holger Rogasch, Julian M. M. Wetz, Christoph J Nucl Cardiol Original Article BACKGROUND: In [(99m)Tc]Tc-DPD scintigraphy for myocardial ATTR amyloidosis, planar images 3 hour p.i. and SPECT/CT acquisition in L-mode are recommended. This study investigated if earlier planar images (1 hour p.i.) are beneficial and if SPECT/CT acquisition should be preferred in H-mode (180° detector angle) or L-mode (90°). METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive and 38 negative patients (reference: endomyocardial biopsy or clinical diagnosis), Perugini scores and heart-to-contralateral (H/CL) count ratios were derived from planar images 1 hour and 3 hour p.i. RESULTS: In phantom measurements, accuracy of myocardial CRpeak at SBR 10:1 (H-mode, 0.95-0.99) and reproducibility at 5:1 (H-mode, 1.02-1.14) was comparable for H-mode and L-mode. However, L-mode showed higher variability of background counts and sphere CRpeak throughout the field of view than H-mode. In patients, sensitivity/specificity were ≥ 95% for H/CL ratios at both time points and visual scoring 3 hour. At 1 hour, visual scores showed specificity of 89% and reduced reader’s confidence. CONCLUSIONS: Early DPD images provided no additional value for visual scoring or H/CL ratios. In SPECT/CT, H-mode is preferred over L-mode, especially if quantification is applied apart from the myocardium. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-021-02715-6. Springer International Publishing 2021-07-30 2021 /pmc/articles/PMC8709821/ /pubmed/34331215 http://dx.doi.org/10.1007/s12350-021-02715-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Schatka, Imke Bingel, Anne Schau, Franziska Bluemel, Stephanie Messroghli, Daniel R. Frumkin, David Knebel, Fabian Diekmann, Sonja M. Elsanhoury, Ahmed Tschöpe, Carsten Hahn, Katrin Amthauer, Holger Rogasch, Julian M. M. Wetz, Christoph An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title | An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title_full | An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title_fullStr | An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title_full_unstemmed | An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title_short | An optimized imaging protocol for [(99m)Tc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis |
title_sort | optimized imaging protocol for [(99m)tc]tc-dpd scintigraphy and spect/ct quantification in cardiac transthyretin (attr) amyloidosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709821/ https://www.ncbi.nlm.nih.gov/pubmed/34331215 http://dx.doi.org/10.1007/s12350-021-02715-6 |
work_keys_str_mv | AT schatkaimke anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT bingelanne anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT schaufranziska anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT bluemelstephanie anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT messroghlidanielr anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT frumkindavid anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT knebelfabian anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT diekmannsonjam anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT elsanhouryahmed anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT tschopecarsten anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT hahnkatrin anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT amthauerholger anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT rogaschjulianmm anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT wetzchristoph anoptimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT schatkaimke optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT bingelanne optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT schaufranziska optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT bluemelstephanie optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT messroghlidanielr optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT frumkindavid optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT knebelfabian optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT diekmannsonjam optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT elsanhouryahmed optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT tschopecarsten optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT hahnkatrin optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT amthauerholger optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT rogaschjulianmm optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis AT wetzchristoph optimizedimagingprotocolfor99mtctcdpdscintigraphyandspectctquantificationincardiactransthyretinattramyloidosis |